WYMM Tour: Toronto
Wednesday, October 16, 2024, 09:00 am-05:00 pm EST - Toronto, Canada
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Wednesday, October 16, 2024, at the MaRS Discovery District to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda below.
Register
Agenda
09:00 am-05:00 pm EST | Agenda (subject to change) | Speaker |
---|---|---|
09:00 am-09:30 am | Registration/Breakfast | |
09:30 am-09:35 am | Welcome | Mark Leno, Oxford Nanopore Technologies |
09:35 am-10:00 am | Nanopore sequencing, the latest and greatest updates | Roger Bialy, Oxford Nanopore Technologies |
10:00 am-10:30 am | Expanding direct RNA-sequencing capabilities for use in multi-omics approaches | Athanasios Zovoilis, University of Manitoba |
10:30 am-11:00 am | Networking Break | |
11:00 am-11:30 am | Considerations for Oxford Nanopore sequencing as a diagnostic tool in a clinical microbiology laboratory | Aaron Campigotto, Hospital for Sick Children |
11:30 am-11:40 am | LIGHTNING TALK: Detecting chromosomal copy number variations and point mutations in Glioma using a single assay | Mashiat Mimosa, University of Toronto |
11:40 am-11:50 am | LIGHTNING TALK: Characterization of tandem repeats and methylation using a graph-based method | Mahreen Khan, Hospital for Sick Children |
11:50 am-12:00 pm | LIGHTNING TALK: Long-read sequencing at single-cell resolution in HER2 negative breast cancer | Tom Ouellette, Ontario Institute for Cancer Research |
12:00 pm-01:00 pm | Lunch | |
01:00 pm-01:30 pm | Exploring Nanopore technology for cell free CSF DNA analyses of rare childhood brain tumors | Annie Huang, Hospital for Sick Children |
01:30 pm-02:00 pm | Oxford Nanopore sequencing enables biodiversity studies at scale | Robin Floyd, University of Guelph |
02:00 pm-02:15 pm | Networking Break | |
02:15 pm-02:45 pm | Oxford Nanopore: technical application updates | Sissel Juul, Oxford Nanopore Technologies |
02:45 pm-03:15 pm | Characterising human cancers and their epigenomes using long read sequencing | Steven Jones, Genome Sciences Centre, BC Cancer |
03:15 pm-03:30 pm | Closing | Mark Leno, Oxford Nanopore Technologies |
03:30 pm-05:00 pm | Networking |
Speakers
Welcome
Mark Leno, Region Sales Director, Oxford Nanopore Technologies
...
Nanopore sequencing, the latest and greatest updates
Roger Bialy, Regional Sequencing Specialist, Oxford Nanopore Technologies
...
Expanding direct RNA-sequencing capabilities for use in multi-omics approaches
Athanasios Zovoilis, University of Manitoba
Dr. Zovoilis is an Associate Professor of Bioinformatics at the Department of Biochemistry and Medic...
Considerations for Oxford Nanopore sequencing as a diagnostic tool in a clinical microbiology laboratory
Aaron Campigotto, Hospital for Sick Children
Aaron Campigotto is a Medical Microbiologist and Head of the Division of Microbiology at The Hospita...
Detecting chromosomal copy number variations and point mutations in Glioma using a single assay
Mashiat Mimosa, PhD Candidate, Laboratory Medicine and Pathobiology, University of Toronto
Mashiat Mimosa is a PhD student in the Department of Laboratory Medicine and Pathobiology at the Uni...
Characterization of tandem repeats and methylation using a graph-based method
Mahreen Khan, PhD Candidate, The Hospital for Sick Children, Canada
Mahreen is a PhD candidate in the Department of Molecular Genetics at The University of Toronto, car...
Nanopore Long-read sequencing at single-cell resolution in HER2 negative breast cancer
Tom Ouellette, PhD Student, Ontario Institute for Cancer Research
Tom Ouellette is a PhD student in the Awadalla lab at the University of Toronto and Ontario Institut...
Exploring Nanopore technology for cell free CSF DNA analyses of rare childhood brain tumors
Annie Huang, Hospital for Sick Children
...
Oxford Nanopore sequencing enables biodiversity studies at scale
Robin Floyd, University of Guelph
I am a molecular biologist of broad experience. Originally from the UK, my PhD (U. of Edinburgh) emp...
Oxford Nanopore: technical application updates
Sissel Juul, VP, Applications, Oxford Nanopore Technologies
Sissel joined Oxford Nanopore 10 years ago and leads the multidisciplinary Applications teams global...
Characterising human cancers and their epigenomes using nanopore long read sequencing
Steve Jones, Co-Director, BC Cancer, Canada
Dr. Jones is Co-Director and Head of Bioinformatics at the Michael Smith Genome Sciences Centre, BC ...